financetom
Business
financetom
/
Business
/
Why Is QuantaSing Stock Gaining Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Is QuantaSing Stock Gaining Today?
Jun 11, 2024 6:03 AM

QuantaSing Group Limited ( QSG ) shares are trading higher in the premarket session on Tuesday.

The Chinese online learning service provider authorized a share repurchase program under which it may repurchase up to $20.0 million of its Class A ordinary shares in the form of American depositary shares.

The repurchase is for twelve months, commencing on June 11, 2024.

“The Share Repurchase Program is well-aligned with our commitment to maximizing value for our shareholders and reflects the Board’s confidence in the Company’s continued growth and long-term prospects,” said Peng Li, QuantaSing’s Chairman and Chief Executive Officer.

On June 9 last year, the company announced that its board of directors had approved a share repurchase program of up to $20.0 million.

As of March 31, the company had cumulatively repurchased an aggregate of approximately 2.6 million ADSs for approximately $11.5 million under the program.

The company had cash and cash equivalents and short-term investments of $159.3 million as of March-end.

For the fourth quarter, the company expects its revenues to be in the range of RMB900.0 million to RMB930.0 million, representing a year-over-year increase of 8.7% to 12.3%.

Price Action: QSG shares are trading higher by 21.5% to $1.98 premarket at last check Tuesday.

Read Next: Tesla Rival Rivian Rolls Out Next-Gen R1S And R1T: Enhanced Performance, Design, And Tech Start At $69,900

Image from Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eyeing the Pacific, Lockheed unveils low-cost $150,000 cruise missile
Eyeing the Pacific, Lockheed unveils low-cost $150,000 cruise missile
Mar 3, 2025
WASHINGTON (Reuters) - Lockheed Martin ( LMT ) plans to unveil a new affordable cruise missile on Monday with a cost of about $150,000 and a range of over 500 miles (800 km) as the defense contractor works to tap a U.S. need to deter Chinese ambitions in the Pacific. Russia's invasion of Ukraine has pushed U.S. and other countries'...
Fox CEO expects new streaming service to attract users in mid-single-digit millions
Fox CEO expects new streaming service to attract users in mid-single-digit millions
Mar 3, 2025
March 3 (Reuters) - Fox Corp's ( FOXA ) upcoming subscription streaming service is expected to draw subscribers in the mid-single-digit millions range, CEO Lachlan Murdoch said on Monday at the Morgan Stanley Technology, Media & Telecom Conference. Fox is planning to launch the yet-to-be-named service by the end of 2025 to diversify its revenue streams and attract an audience...
PayPal-backed Mintoak strikes India's first e-rupee related deal, worth $3.5 million, sources say
PayPal-backed Mintoak strikes India's first e-rupee related deal, worth $3.5 million, sources say
Mar 3, 2025
NEW DELHI, March 4 (Reuters) - Indian startup Mintoak, which provides merchant payment services to lenders, said on Tuesday it has bought Digiledge, marking the first acquisition in the nascent central bank digital currency space in a deal that sources said was worth around $3.5 million. The Reserve Bank of India started a pilot for the CBDC, or e-rupee, a...
Axsome Therapeutics Receives FDA Indication in Support of Alzheimer's Drug Submission
Axsome Therapeutics Receives FDA Indication in Support of Alzheimer's Drug Submission
Mar 3, 2025
01:42 PM EST, 03/03/2025 (MT Newswires) -- Axsome Therapeutics ( AXSM ) said Monday it received feedback from the US Food and Drug Administration supporting a submission of its drug for Alzheimer's disease agitation for approval. Meeting minutes from the company's pre-new drug application huddle with the FDA indicated that the company's regulatory data package for AXS-05 would support a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved